rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Abbott Laboratories

ABT · NYSE

Health CareBiotechnologyAbove a falling average

ABT stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 6.2% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$8.8M
Insider sales, 12 months
$94.9M
Officials’ trades on record
172

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$90.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

172 disclosed lines: House 140, Senate 27, executive 5; 59 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k18 Sep 2026filed 12 Oct 2026
Richard McCormick House: U.S. House ClerkGA06sold$1k–$15k30 Jul 2026filed 14 Aug 2026
Mike Kelly House: U.S. House ClerkPA16soldspouse$1k–$15k17 Jul 2026filed 12 Aug 2026
Rick W. Allen House: U.S. House ClerkGA12soldspouse$15k–$50k14 Jul 2026filed 18 Aug 2026
Rick Larsen House: U.S. House ClerkWA02sold$1k–$15k8 Jul 2026filed 12 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k16 Jun 2026filed 2 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k12 Jun 2026filed 22 Aug 2026
Richard McCormick House: U.S. House ClerkGA06bought$1k–$15k12 Jun 2026filed 9 Jul 2026
Richard McCormick House: U.S. House ClerkGA06bought$1k–$15k12 Jun 2026filed 9 Jul 2026
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k27 May 2026filed 3 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k15 May 2026filed 8 Jun 2026
Julie Johnson House: U.S. House ClerkTX32soldjoint$1k–$15k12 May 2026filed 12 Jun 2026

Insiders

Buy orders, 12 months5
Sale orders, 12 months10
Buyers · sellers4 · 7
WhoDidSharesTraded
John A. McCoy, Jr.VICE PRESIDENT AND CONTROLLERsold27at $109.542 Sep 2026filed 3 Sep 2026
Robert B. FordCHAIRMAN AND CEOsold218,535at $115.5725 Aug 2026filed 27 Aug 2026
Robert B. FordCHAIRMAN AND CEOsold180,297at $116.1925 Aug 2026filed 27 Aug 2026
Louis H. MorroneEXECUTIVE VICE PRESIDENTsold5,850at $109.8311 Aug 2026filed 13 Aug 2026
John G. StrattonDirectorbought2,000at $86.827 May 2026filed 18 Jun 2026
Daniel J. StarksDirectorbought10,000at $92.6527 Apr 2026filed 28 Apr 2026
Philip P. BoudreauEVP AND CFObought2,200at $91.5023 Apr 2026filed 27 Apr 2026
Daniel Gesua Sive SalvadoriEVP AND GROUP PRESIDENTsold885at $115.582 Mar 2026filed 3 Mar 2026
John A. McCoy, Jr.VICE PRESIDENT AND CONTROLLERsold585at $115.582 Mar 2026filed 3 Mar 2026
Mary K. MorelandEXECUTIVE VICE PRESIDENTsold613at $115.582 Mar 2026filed 3 Mar 2026
Louis H. MorroneEXECUTIVE VICE PRESIDENTsold1,144at $115.582 Mar 2026filed 3 Mar 2026
Eric ShroffSenior Vice Presidentsold709at $115.582 Mar 2026filed 3 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

News

Everyone who traded it

John G. Stratton Company insiderDirector · last 30 Sep 20262 · 0
Kevin T. Conroy Company insiderDirector · last 30 Sep 20260 · 0
Michael F. Roman Company insiderDirector · last 30 Sep 20260 · 0
Nita Ahuja Company insiderDirector · last 30 Sep 20260 · 0
Patricia Paola Gonzalez Company insiderDirector · last 30 Sep 20260 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 18 Sep 20264 · 3
John A. McCoy Jr. Company insiderVICE PRESIDENT AND CONTROLLER · last 2 Sep 20260 · 5
Philip P. Boudreau Company insiderEVP AND CFO · last 1 Sep 20261 · 4
Robert B. Ford Company insiderCHAIRMAN AND CEO · last 25 Aug 20262 · 7
Louis H. Morrone Company insiderEXECUTIVE VICE PRESIDENT · last 12 Aug 20260 · 10
Richard McCormick HouseGA06 · last 30 Jul 20265 · 1
Mike Kelly HousePA16 · last 17 Jul 20260 · 1

157 people in all.

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202556.4%
Operating profit marginFY 2025 · to 31 Dec 202518.2%
Free cash flow marginFY 2025 · to 31 Dec 202516.7%
Return on capital employedFY 2025 · to 31 Dec 202511.5%
Cash conversionFY 2025 · to 31 Dec 2025147%
Debt to equityFY 2025 · to 31 Dec 20250.31×
Research spendFY 2025 · to 31 Dec 20256.6%
Share count trendFY 2025 · to 31 Jan 2026-0.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.5B
Free cash flowFY 2025 · to 31 Dec 2025$7.4B

Analyst forecasts

No analyst forecasts yet.